Supplemental material
Open access
1,215
Views
5
CrossRef citations to date
0
Altmetric
Short Communication
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
Naresh SunduruDepartment of Chemistry, Umeå University, Umeå, Sweden; View further author information
, Mona SvenssonDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden; View further author information
, Mariateresa CiprianoDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden; View further author information
, Sania MarwahaDepartment of Chemistry, Umeå University, Umeå, Sweden; View further author information
, C. David AnderssonDepartment of Chemistry, Umeå University, Umeå, Sweden; View further author information
, Richard SvenssonDepartment of Pharmacy, Uppsala Drug Optimization and Pharmaceutical Profiling platform (UDOPP), Uppsala University, Uppsala, SwedenView further author information
, Christopher J. FowlerDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden; View further author information
& Mikael ElofssonDepartment of Chemistry, Umeå University, Umeå, Sweden; Correspondence[email protected]
http://orcid.org/0000-0002-3219-4669View further author information
Pages 513-521
|
Received 01 Sep 2016, Accepted 21 Oct 2016, Published online: 23 Jan 2017
Related Research Data
Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
Source:
Springer Science and Business Media LLC
Synthesis of analogues of the 2-O-alkyl glycerate part of the moenomycins
Source:
Elsevier BV
The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
Source:
Elsevier BV
Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)
Source:
Proceedings of the National Academy of Sciences
Actions of FAAH inhibition in chronic pain states
Source:
Wiley
Erratum to “The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH” [Pharmacol. Res. 54 (2006) 481–485]
Source:
Elsevier BV
The Preparation of 2-Arylimidazo[4,5-b]pyridines
Source:
American Chemical Society (ACS)
Quantum Mechanics/Molecular Mechanics Modeling of Fatty Acid Amide Hydrolase Reactivation Distinguishes Substrate from Irreversible Covalent Inhibitors
Source:
American Chemical Society (ACS)
Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Source:
eScholarship, University of California
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
Source:
Bentham Science Publishers Ltd.
Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
Source:
Proceedings of the National Academy of Sciences
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators.
Source:
Elsevier BV
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
Source:
Umeå universitet, Kemiska institutionen
Mechanisms of analgesia by FAAH inhibition
Source:
Wiley
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.
Source:
Elsevier BV
Semianalytical treatment of solvation for molecular mechanics and dynamics
Source:
American Chemical Society (ACS)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.